ClinicalTrials.Veeva

Menu

Evaluating the Human Papillomavirus Self-Collection Experience in Individuals Who Have Experienced Sexual Trauma

OHSU Knight Cancer Institute logo

OHSU Knight Cancer Institute

Status

Completed

Conditions

Human Papillomavirus Infection
Cervical Carcinoma

Treatments

Other: Survey Administration
Other: Interview
Procedure: HPV Self-Collection

Study type

Observational

Funder types

Other

Identifiers

NCT05458869
NCI-2022-05454 (Registry Identifier)
STUDY00024429 (Other Identifier)

Details and patient eligibility

About

This study explores the human papillomavirus (HPV) self-collection experience among individuals with a history of sexual trauma. Cervical cancer is the fourth most common cancer in women worldwide and is the second leading cause of cancer-related death in women ages 29-39. Despite programs to improve accessibility of cervical cancer screening and overall high screening rates, disparities in routine surveillance have been demonstrated in certain populations, such as victims of intimate partner violence and sexual trauma. One barrier to participating in cervical cancer screening for this population is the office-based visit which necessitates the individual to undress, sit with their legs in stirrups, and undergo speculum examination for specimen collection. This type of visit may cause distress for participants who have experienced sexual violence. HPV self-collection has been studied with favorable outcomes in effectiveness and ease of use. This study evaluates the experience of HPV self-collection among individuals who have experienced sexual trauma.

Full description

PRIMARY OBJECTIVE:

I. To explore the HPV self-collection experience among individuals with a history of sexual trauma.

OUTLINE:

Participants complete a survey, use an HPV self-collection kit, and attend an interview over 30 minutes.

Enrollment

16 patients

Sex

Female

Ages

25+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Individuals with a cervix who are eligible for primary HPV testing (age 25 and older) according to national cervical cancer screening guidelines
  • Identify themselves as having a history of IPV, sexual abuse, or sexual trauma
  • Participants will also need to have access to a smartphone, tablet, or computer with video capability
  • English speaking
  • Reside in the State of Oregon
  • Patients who have participated in prior HPV self-collection study (reference Institutional Review Board [IRB] number- IRB# 23478) will also be eligible to participate in the interview if they meet the remaining eligibility requirements (i.e. history of IPV, sexual abuse, sexual trauma)

Exclusion criteria

  • Individuals who are not English speaking
  • Individuals < 25 years old or no longer eligible/recommended to undergo cervical cancer screening
  • Resides outside the state of Oregon
  • Adults who are unable to consent or are decisionally impaired
  • Individuals without a cervix (i.e. prior hysterectomy)

Trial design

16 participants in 1 patient group

Observational (survey, HPV self-collection, interview)
Description:
Participants complete a survey, use an HPV self-collection kit, and attend an interview over 30 minutes.
Treatment:
Other: Interview
Other: Survey Administration
Procedure: HPV Self-Collection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems